Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

ミソプロストールと潰瘍予防

M J Shield, C G Fenn

    Lancet (London, England)
    |January 14, 1989
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    Low-dose misoprostol for the prevention of low-dose aspirin-induced gastroduodenal injury.

    Alimentary pharmacology & therapeutics·2000
    Same author

    Diclofenac/misoprostol: novel findings and their clinical potential.

    The Journal of rheumatology. Supplement·1998
    Same author

    Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study.

    BMJ (Clinical research ed.)·1997
    Same author

    Gastrointestinal complications and meloxicam.

    British journal of rheumatology·1997
    Same author

    Misoprostol in patients taking non-steroidal anti-inflammatory drugs. Analysis excluded in important events.

    BMJ (Clinical research ed.)·1996
    Same author

    Effect of longterm misoprostol coadministration with non-steroidal anti-inflammatory drugs: a histological study.

    Gut·1995
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    関連記事をすべて見る